Clinical Trial Update: A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results update of pemetrexed in combination with doxorubicin for advanced breast cancer (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Alimta (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED